BRIEF-Nanobiotix expects first European market authorization for NBTXR3 in 2017
* Announced on Tuesday that first European market authorization for NBTXR3 is expected in 2017 [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: NBTXR3, European, first, expected, market authorization, Announced, authorization, market, expects, BRIEF-Nanobiotix
Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/BmVvhEJFFMU/idUSL5N1FM26C